Prudential Financial’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.24M | Sell |
|
|||||
|
2025
Q2 | $2.86M | Sell |
|
|||||
|
2025
Q1 | $3.26M | Sell |
|
|||||
|
2024
Q4 | $3.71M | Sell |
|
|||||
|
2024
Q3 | $3.64M | Sell |
|
|||||
|
2024
Q2 | $4.39M | Sell |
|
|||||
|
2024
Q1 | $4.51M | Sell |
|
|||||
|
2023
Q4 | $6.49M | Buy |
|
|||||
|
2023
Q3 | $6.41M | Buy |
|
|||||
|
2023
Q2 | $7.74M | Buy |
|
|||||
|
2023
Q1 | $7.22M | Buy |
|
|||||
|
2022
Q4 | $5.88M | Buy |
|
|||||
|
2022
Q3 | $6.73M | Buy |
|
|||||
|
2022
Q2 | $5.71M | Buy |
|
|||||
|
2022
Q1 | $5.78M | Sell |
|
|||||
|
2021
Q4 | $8.15M | Sell |
|
|||||
|
2021
Q3 | $11.1M | Sell |
|
|||||
|
2021
Q2 | $16.6M | Sell |
|
|||||
|
2021
Q1 | $13.2M | Sell |
|
|||||
|
2020
Q4 | $13.5M | Sell |
|
|||||
|
2020
Q3 | $10M | Sell |
|
|||||
|
2020
Q2 | $15.5M | Buy |
|
|||||
|
2020
Q1 | $13.2M | Buy |
|
|||||
|
2019
Q4 | $20.8M | Buy |
|
|||||
|
2019
Q3 | $12.7M | Buy |
|
|||||
|
2019
Q2 | $4.95M | Buy |
|
|||||
|
2019
Q1 | $6.34M | Sell |
|
|||||
|
2018
Q4 | $17.5M | Sell |
|
|||||
|
2018
Q3 | $18.2M | Sell |
|
|||||
|
2018
Q2 | $15.8M | Sell |
|
|||||
|
2018
Q1 | $14.3M | Buy |
|
|||||
|
2017
Q4 | $10.7M | Buy |
|
|||||
|
2017
Q3 | $10.5M | Buy |
|
|||||
|
2017
Q2 | $9.48M | Sell |
|
|||||
|
2017
Q1 | $8.6M | Buy |
|
|||||
|
2016
Q4 | $9.72M | Buy |
|
|||||
|
2016
Q3 | $9.96M | Buy |
|
|||||
|
2016
Q2 | $3.96M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $771K | Buy |
|
|||||
|
2014
Q1 | $714K | Buy |
|
|||||
|
2013
Q4 | $544K | Sell |
|
|||||
|
2013
Q3 | $947K | Buy |
|
|||||
|
2013
Q2 | $525K | Buy |
|